Clinical Trial Update: A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia [Phase 3]

View source ↗

Summary

Phase 3 study comparing Romiplostim N01 plus immunosuppressive therapy versus placebo plus IST in treatment-naive severe aplastic anemia. The trial is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Romiplostim N01 Plus IST (romiplostim)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Treatment-naïve Severe Aplastic Anemia | Phase 3 | Status: NOT_YET_RECRUITING